Intuitive Surgical (ISRG) official guidance
Intuitive Surgical (ISRG) official earnings guidance and management outlook. Each figure management stated is shown with its revisions and the source quote.
See the full Filings Intelligence suiteISRGINTUITIVE SURGICAL INCFY2026 · ends 2026-12-31
10 metrics1 lowered3 new6 maintainedearnings call · 2026-07-17 04:01:07 UTC
2026-07-17 04:01:07 UTC13.5% – 15.5%maintained13.5% – 15.5% vs FY2025
In April, we forecast full year 2026 da Vinci procedure growth to be within a range of 13.5%-15.5%.
ISRG · transcript · Q2 FY2026
2026-07-17 04:00:00 UTCOpen source
2026-07-16 20:05:45 UTC13.5% – 15.5%maintained13.5% – 15.5% vs FY2025
•Worldwide da Vinci procedure growth of approximately 13.5% to 15.5% in 2026. The Company expects to be closer to the midpoint of this range.
ISRG · EX-99.1 · Q2 FY2026
2026-07-16 20:05:17 UTCOpen source
2026-04-22 04:00:51 UTC13.5% – 15.5%maintained13.5% – 15.5% vs FY2025
We are increasing our forecast and now expect full-year da Vinci procedure growth within a range of 13.5%-15.5%.
ISRG · transcript · Q1 FY2026
2026-04-22 04:00:00 UTCOpen source
2026-04-21 20:10:07 UTC13.5% – 15.5%raised +3.6%13.5% – 15.5% vs FY2025
Worldwide da Vinci procedure growth of approximately 13.5% to 15.5% in 2026.
ISRG · EX-99.1 · Q1 FY2026
2026-04-21 20:09:36 UTCOpen source
2026-01-23 05:01:14 UTC13% – 15%maintained13% – 15% vs FY2025
For 2026, we anticipate full-year da Vinci procedure growth within a range of 13%-15%.
ISRG · transcript · Q4 FY2025
2026-01-23 05:00:00 UTCOpen source
2026-01-22 21:05:51 UTC13% – 15%maintained13% – 15% vs FY2025
Worldwide da Vinci procedure growth of approximately 13% to 15% in 2026, compared to 18% in 2025.
ISRG · EX-99.1 · Q4 FY2025
2026-01-22 21:05:12 UTCOpen source
2026-01-14 13:59:22 UTC13% – 15%new13% – 15% vs FY2025
The Company expects worldwide da Vinci procedures to increase approximately 13% to 15% in 2026 as compared with 2025.
ISRG · EX-99.1 · Q4 FY2025
2026-01-14 13:58:49 UTCOpen source
2026-07-17 04:01:07 UTC22% – 23%maintained
With regard to income tax, we continue to expect our non-GAAP income tax rate to be between 22% and 23% of pre-tax income.
ISRG · transcript · Q2 FY2026
2026-07-17 04:00:00 UTCOpen source
2026-04-22 04:00:51 UTC22% – 23%maintained
With regard to income tax, we continue to expect our non-GAAP income tax rate to be between 22%-23% of pre-tax income.
ISRG · transcript · Q1 FY2026
2026-04-22 04:00:00 UTCOpen source
2026-01-23 05:01:14 UTC22% – 23%new
As we look forward, we estimate our 2026 pro forma income tax rate to be within a range of 22%-23% of pre-tax income.
ISRG · transcript · Q4 FY2025
2026-01-23 05:00:00 UTCOpen source
2026-07-17 04:01:07 UTCdo not expect to make a contribution to the foundation in 2026new
Additionally, in Q4 2025, we made a $70 million multi-year contribution to the Intuitive Foundation. We do not expect to make a contribution to the foundation in 2026.
ISRG · transcript · Q2 FY2026
2026-07-17 04:00:00 UTCOpen source
2026-07-17 04:01:07 UTC68% – 69%maintained
On our last call, we forecast non-GAAP gross profit margin to be within a range of 67.5% and 68.5% of revenue, which reflected 100 basis points of impact from tariff. We are updating our estimate for non-GAAP gross profit margin to be within a range of 68% and 69% of revenue.
ISRG · transcript · Q2 FY2026
2026-07-17 04:00:00 UTCOpen source
2026-07-16 20:05:45 UTC68% – 69%raised +0.7%
•Non-GAAP* gross profit margin to be within a range of 68.0% to 69.0% of revenue in 2026. This range includes an estimated impact from tariffs of 1.0% of revenue.
ISRG · EX-99.1 · Q2 FY2026
2026-07-16 20:05:17 UTCOpen source
2026-04-22 04:00:51 UTC67.5% – 68.5%maintained
We are updating our estimate for non-GAAP gross profit margin to be within a range of 67.5%-68.5% of revenue, which now reflects 100 basis points of impact from tariffs, as well as higher input costs in other areas, including freight and semiconductor memory.
ISRG · transcript · Q1 FY2026
2026-04-22 04:00:00 UTCOpen source
2026-04-21 20:10:07 UTC67.5% – 68.5%raised +0.7%
Non-GAAP\* gross profit margin to be within a range of 67.5% and 68.5% of revenue in 2026.
ISRG · EX-99.1 · Q1 FY2026
2026-04-21 20:09:36 UTCOpen source
2026-01-23 05:01:14 UTC67% – 68%maintained
In 2026, we expect our pro forma gross profit margin to be within a range of 67% and 68% of net revenue.
ISRG · transcript · Q4 FY2025
2026-01-23 05:00:00 UTCOpen source
2026-01-22 21:05:51 UTC67% – 68%new
Non-GAAP\* gross profit margin to be within a range of 67% and 68% of revenue in 2026, compared to 67.6% in 2025.
ISRG · EX-99.1 · Q4 FY2025
2026-01-22 21:05:12 UTCOpen source
2026-07-17 04:01:07 UTC11% – 13%maintained11% – 13% vs FY2025
In regard to operating expenses, we now expect non-GAAP operating expense growth to be between 11% and 13%.
ISRG · transcript · Q2 FY2026
2026-07-17 04:00:00 UTCOpen source
2026-07-16 20:05:45 UTC11% – 13%lowered -4.0%11% – 13% vs FY2025
•Non-GAAP* operating expense growth of 11% to 13% in 2026.
ISRG · EX-99.1 · Q2 FY2026
2026-07-16 20:05:17 UTCOpen source
2026-04-22 04:00:51 UTC11% – 14%maintained11% – 14% vs FY2025
In regard to operating expenses, we now expect non-GAAP operating expense growth to be between 11%-14%.
ISRG · transcript · Q1 FY2026
2026-04-22 04:00:00 UTCOpen source
2026-04-21 20:10:07 UTC11% – 14%lowered -3.8%11% – 14% vs FY2025
Non-GAAP\* operating expense growth of 11% to 14% in 2026.
ISRG · EX-99.1 · Q1 FY2026
2026-04-21 20:09:36 UTCOpen source
2026-01-23 05:01:14 UTC11% – 15%maintained11% – 15% vs FY2025
In 2026, we expect pro forma operating expense growth to be within a range of 11%-15% due to higher spending in support of advancing early-stage R&D programs, as well as incremental expenses associated with our distributor acquisition.
ISRG · transcript · Q4 FY2025
2026-01-23 05:00:00 UTCOpen source
2026-01-22 21:05:51 UTC11% – 15%new11% – 15% vs FY2025
Non-GAAP\* operating expense growth of 11% to 15% in 2026, compared to 12% in 2025.
ISRG · EX-99.1 · Q4 FY2025
2026-01-22 21:05:12 UTCOpen source
2026-07-17 04:01:07 UTC$315M – $335Mmaintained
We continue to forecast other income, which is comprised mostly of interest income, to total between $315 million and $335 million.
ISRG · transcript · Q2 FY2026
2026-07-17 04:00:00 UTCOpen source
2026-04-22 04:00:51 UTC$315M – $335Mlowered -11.0%
We now forecast other income, which is comprised mostly of interest income, to total between $315 million-$335 million, due primarily to lower average cash balances following share repurchase activity in Q1.
ISRG · transcript · Q1 FY2026
2026-04-22 04:00:00 UTCOpen source
2026-01-23 05:01:14 UTC$355M – $375Mnew
We forecast other income, which is comprised mostly of interest income, to total between $355 million-$375 million.
ISRG · transcript · Q4 FY2025
2026-01-23 05:00:00 UTCOpen source
2026-07-17 04:01:07 UTC$880M – $900Mlowered -1.7%
We now estimate non-cash stock compensation expense between $880 million and $900 million.
ISRG · transcript · Q2 FY2026
2026-07-17 04:00:00 UTCOpen source
2026-04-22 04:00:51 UTC$890M – $920Mmaintained
We continue to estimate non-cash stock compensation expense between $890 million-$920 million.
ISRG · transcript · Q1 FY2026
2026-04-22 04:00:00 UTCOpen source
2026-01-23 05:01:14 UTC$890M – $920Mnew
We estimate non-cash stock compensation expense between $890 million-$920 million.
ISRG · transcript · Q4 FY2025
2026-01-23 05:00:00 UTCOpen source
2026-01-23 05:01:14 UTChigher da Vinci 5 mix in 2026 versus 2025new
You should expect a higher da Vinci 5 mix in 2026 versus 2025.
ISRG · transcript · Q4 FY2025
2026-01-23 05:00:00 UTCOpen source
2026-01-23 05:01:14 UTC1.2%maintained
This year, we forecast an impact from tariffs of 1.2% of net revenue, ±10 basis points.
ISRG · transcript · Q4 FY2025
2026-01-23 05:00:00 UTCOpen source
2026-01-22 21:05:51 UTC1.2%new
Non-GAAP\* gross profit margin to be within a range of 67% and 68% of revenue in 2026, compared to 67.6% in 2025. This range includes an estimated impact from tariffs of 1.2% of revenue, plus or minus 10 basis points.
ISRG · EX-99.1 · Q4 FY2025
2026-01-22 21:05:12 UTCOpen source
2026-01-23 05:01:14 UTChigher mix of XIRnew
You should also expect a higher mix of XIR.
ISRG · transcript · Q4 FY2025
2026-01-23 05:00:00 UTCOpen source
ISRGINTUITIVE SURGICAL INCFY2025 · ends 2025-12-31
8 metrics5 new3 maintainedearnings call · 2025-10-22 04:00:59 UTC
2025-10-22 04:00:59 UTC$625M – $675Mnew-43.8% – -39.3% vs FY2024
We expect capital expenditures to range between $625 million and $675 million, which reflects planned facility construction activities.
ISRG · transcript · Q3 FY2025
2025-10-22 04:00:00 UTCOpen source
2025-10-22 04:00:59 UTC17% – 17.5%maintained17% – 17.5% vs FY2024
Starting with Da Vinci procedure growth, on our last call, we forecast full-year 2025 Da Vinci procedure growth within a range of 15.5% and 17%. We are updating our 2025 Da Vinci procedure growth guidance to be within a range of 17% and 17.5%.
ISRG · transcript · Q3 FY2025
2025-10-22 04:00:00 UTCOpen source
2025-10-21 20:04:15 UTC17% – 17.5%new17% – 17.5% vs FY2024
Worldwide da Vinci procedure growth of approximately 17% to 17.5% in 2025, compared to 17% in 2024.
ISRG · EX-99 · Q3 FY2025
2025-10-21 20:03:44 UTCOpen source
2025-10-22 04:00:59 UTC21% – 22%new
With regard to income tax, due primarily to the lower Q3 non-GAAP effective tax rate that Jamie described earlier, we now estimate our 2025 pro forma income tax rate to be between 21% and 22%.
ISRG · transcript · Q3 FY2025
2025-10-22 04:00:00 UTCOpen source
2025-10-22 04:00:59 UTC67% – 67.5%maintained
Turning to gross profit, on our last call, we forecast pro forma gross profit margin in 2025 to be within a range of 66% and 67% of revenue. Given Q3 results, which reflected greater leverage of fixed costs and benefits from cost reductions, as well as a lower expected tariff impact for the year, we are updating our estimate of pro forma gross margin to be within a range of 67% and 67.5% of revenue.
ISRG · transcript · Q3 FY2025
2025-10-22 04:00:00 UTCOpen source
2025-10-21 20:04:15 UTC67% – 67.5%new
Non-GAAP* gross profit margin to be within a range of 67% and 67.5% of revenue in 2025, compared to 69.1% in 2024. This range includes an estimated impact from tariffs of 0.7% of revenue, plus or minus 10 basis points.
ISRG · EX-99 · Q3 FY2025
2025-10-21 20:03:44 UTCOpen source
2025-10-22 04:00:59 UTC11% – 13%maintained11% – 13% vs FY2024
We expect pro forma operating expense growth to be between 11% and 13%, which includes increased depreciation from new facilities and investments to drive our growth objectives.
ISRG · transcript · Q3 FY2025
2025-10-22 04:00:00 UTCOpen source
2025-10-21 20:04:15 UTC11% – 13%new11% – 13% vs FY2024
Non-GAAP* operating expense growth of 11% to 13% in 2025, compared to 10% in 2024.
ISRG · EX-99 · Q3 FY2025
2025-10-21 20:03:44 UTCOpen source
2025-10-22 04:00:59 UTC$350M – $360Mnew
We forecast other income, which is comprised mostly of interest income, to total between $350 million and $360 million.
ISRG · transcript · Q3 FY2025
2025-10-22 04:00:00 UTCOpen source
2025-10-22 04:00:59 UTC$785M – $795Mnew
We estimate non-cash stock compensation expense to be between $785 million and $795 million.
ISRG · transcript · Q3 FY2025
2025-10-22 04:00:00 UTCOpen source
2025-10-22 04:00:59 UTC70 bpsnew
Within that range, we now expect the impact of tariffs for the year to be 70 basis points plus or minus 10 basis points.
ISRG · transcript · Q3 FY2025
2025-10-22 04:00:00 UTCOpen source